Thomas SJ, Perez JL, Lockhart SP, Hariharan S, et al. Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial. Vaccine 2021 Dec 24. pii: S0264-410X(21)01652.
PMID: 35131133